The use of genetically modified pig models for hypercholesterolemia and atherosclerosis [79], T2DM [80], or over-expression of endothelial nitric oxide synthase [81] could be useful in that aim, before clinical studies. This evidence concerns the gene NOS3 and Hypercholesterolemia.